CLNNW लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (25 Jun 2024 @ 01:30):
Our systems believe the stock currently is overvalued by -5.52% compare to its pairs and should correct downwards.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics...

Stats
आज की मात्रा	50 356
औसत मात्रा	0
बाजार मूल्य	52.26M
EPS	$-0.0863 ( Q1 \| 2024-05-08 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 24.32
ATR14	$0 (0.00%)

AADI -2.65%

ABCL 1.79%

ABCM 0.04%

ABEO -2.84%

ABIO -0.98%

ABOS 0.70%

ABSI 2.89%

ABUS -2.46%

ABVX -3.53%

ACAD -0.83%

ACER -17.95%

ACET -3.40%

ACGN 1.29%

ACHL -4.15%

ACHV -1.72%

ACIU -0.50%

ACLX 0.02%

ACRV -4.79%

ACST -1.63%

ACXP 0.65%

ADAG 4.64%

ADAP -2.80%

ADGI 0.87%

ADIL 0.54%

ADMA -2.41%

ADPT -0.44%

ADTX -3.47%

ADVM -3.18%

ADXN -1.60%

AEON -3.74%

AEZS -3.51%

AFMD -1.40%

AGEN -1.61%

AGIO -1.88%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA -3.13%

AKRO -2.70%

AKTX 4.08%

AKUS 0.00%

ALBO 0.00%

ALDX -2.11%

ALEC -3.90%

ALGS -2.41%

ALKS -0.21%

ALLK -8.90%

ALLO -6.64%

ALLR -4.09%

ALNA 3.16%

ALNY 1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -9.45%

ALVR -0.59%

ALXN 0.00%

ALXO -10.65%

ALZN 4.78%

AMRN 0.26%

AMTI -3.13%

ANAB 0.42%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.44%

ANPC -3.15%

APGE -0.96%

APGN 8.48%

APGNW 30.65%

APLM 1.56%

APLS 0.22%

APLT -3.94%

APM -1.47%

APOP 0.38%

APRE 2.29%

APTO 4.70%

APTX 3.17%

APVO 0.18%

ARAV -13.39%

ARCT -4.03%

ARDS -14.23%

ARDX -0.91%

ARGX -0.93%

ARNA 0.00%

ARPO -0.90%

ARQT -0.52%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.19%

ARWR -1.77%

ASLN -3.44%

ASMB -3.83%

ASND -0.91%

ATAI -1.48%

ATHA 5.94%

ATHE 1.12%

ATHX -33.50%

ATNF 0.98%

ATOS 3.86%

ATRA -2.89%

ATXI 1.93%

ATXS -0.89%

AUPH -0.99%

AURA -0.15%

AUTL -1.87%

AVBP -2.79%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -5.52%

AVTX -1.25%

AVXL -2.84%

AXLA 0.00%

AXSM -1.73%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.52%

BCAB 3.92%

BCDA -2.07%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.60%

BCRX 1.56%

BCTX 8.12%

BCTXW -21.88%

BCYC 0.55%

BDRX -5.90%

BDTX -0.85%

BEAM 0.08%

BFRA -2.91%

BGNE -2.19%

BIOR -3.40%

BIVI 0.56%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.85%

BLTE -0.62%

BLU 0.03%

BLUE -0.81%

BMEA -9.77%

BMRN 0.34%

BNOX -2.22%

BNTC -2.11%

BNTX -1.21%

BOLD -8.23%

BOLT -0.18%

BPMC -1.22%

BPTH 1.86%

BPTS -13.47%

BRNS -0.74%

BRTX -2.38%

BTAI 24.58%

BTTX 53.33%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 3.33%

CABA 0.90%

CADL -1.23%

CALA 0.00%

CALC -1.77%

CALT -0.59%

CAPR -3.01%

CARA -0.62%

CARM 12.13%

CASI -1.67%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -7.00%

CCCC -5.26%

CCXI 0.00%

CDAK 0.00%

CDIO -3.09%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -10.57%

CDTTW -39.60%

CDTX -1.92%

CDXC -0.41%

CDXS 4.31%

CELC -3.82%

CELU -1.50%

CELUW 11.80%

CERC -1.68%

CERE -0.78%

CERO -3.60%

CEROW -10.18%

CFRX -27.95%

CGEM -2.74%

CGEN -3.31%

CGON -0.13%

CGTX -4.55%

CHMA -6.00%

CHRS -0.63%

CINC 0.00%

CING 0.70%

CINGW 34.95%

CKPT -2.89%

CLBS -16.75%

CLDX -2.32%

CLGN 0.34%

CLLS -4.15%

CLNN 2.42%

CLNNW 0.00%

CLRB 7.41%

CLSD -2.90%

CLSN -0.68%

CLVS 0.00%

CMMB -0.01%

CMND 3.63%

CMPI 0.00%

CMPX -8.23%

CMRA 0.00%

CMRAW 33.33%

CMRX -2.71%

CNCE 0.00%

CNSP -41.20%

CNST 0.00%

CNTA -0.73%

CNTB -2.25%

CNTX -6.85%

COCP -2.02%

COEPW 32.45%

COGT -3.00%

CORT 2.30%

COYA -1.46%

CPRX -0.79%

CRBP -1.85%

CRBU -4.84%

CRDF -2.21%

CRGX 1.27%

CRIS -0.38%

CRNX -6.21%

CRSP 0.99%

CRTX 2.63%

CRVO -2.50%

CRVS 1.12%

CSBR -1.59%

CTCX -1.63%

CTIC 0.06%

CTMX -2.50%

CTNM -2.13%

CTXR 1.13%

CUE 3.53%

CVAC -1.98%

CVKD 0.15%

CWBR 2.80%

CYAD -12.96%

CYCC 9.84%

CYCCP 5.49%

CYCN 0.43%

CYT -2.27%

CYTK -2.04%

CYTO -2.73%

DARE 6.54%

DAWN 0.30%

DBTX -0.81%

DBVT -2.08%

DFFN 10.28%

DICE 0.06%

DMAC 32.60%

DNLI -1.97%

DNTH -6.01%

DOMH -1.58%

DRMA -1.10%

DRMAW -1.25%

DRNA 0.00%

DRTS 1.85%

DRTSW 0.00%

DRUG 0.95%

DSGN -1.51%

DTIL 0.89%

DYAI 9.68%

EARS -1.77%

EDIT -2.51%

EDSA -1.00%

EFTR 7.18%

EFTRW -51.85%

EIGR -9.21%

ELAB -1.00%

ELDN 7.98%

ELEV -5.19%

ELOX 7.69%

ELTX -0.88%

ELVN -4.52%

ELYM 0.77%

ENGN 1.67%

ENGNW 0.12%

ENLV 2.54%

ENOB 1.79%

ENSC 5.11%

ENTA -0.49%

ENTO -0.07%

ENTX 0.69%

ENVB 1.10%

EPIX -0.10%

EPRX -2.97%

EPZM 0.00%

EQ 0.86%

EQRX -2.09%

EQRXW 0.00%

ERAS -1.44%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 87.05%

ETNB -0.51%

ETON -0.30%

ETTX 0.00%

EVAX -2.14%

EVGN 6.35%

EVLO 0.00%

EWTX -0.03%

EXAI -0.76%

EXEL -0.27%

EYEG -0.69%

EYEN 1.54%

EYPT 0.00%

FATE -8.06%

FBIO 0.59%

FBIOP 0.92%

FBLG -17.00%

FBRX -0.04%

FDMT -4.59%

FENC -1.29%

FGEN -4.70%

FHTX 1.43%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -2.53%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.53%

FULC -3.51%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.73%

GANX -1.42%

GBIO -2.12%

GBT 0.01%

GDTC 0.50%

GERN -3.54%

GHRS -2.85%

GLMD -2.15%

GLPG -2.30%

GLSI 2.80%

GLTO -1.20%

GLUE -1.58%

GLYC -9.59%

GMAB -0.47%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -0.52%

GNLX 1.56%

GNPX 0.98%

GNTA 3.94%

GOSS -7.81%

GOVX 4.50%

GOVXW -49.04%

GPCR -6.86%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 0.14%

GRTX 0.00%

GTHX 0.02%

GUTS -4.85%

GXGXW 41.67%

GYRE -7.08%

HALO -0.77%

HARP 0.09%

HCWB -3.75%

HEPA 2.80%

HGEN -84.62%

HILS 5.66%

HLVX -1.91%

HOOK 1.13%

HOTH -2.70%

HOWL -2.14%

HRMY 1.10%

HRTX 1.97%

HSTO 0.00%

HUMA 1.12%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 16.67%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -1.50%

IFRX -2.66%

IGMS -0.11%

IKNA 0.60%

IKT 1.42%

IMAB -0.58%

IMCR -2.60%

IMGN 0.02%

IMGO 0.00%

IMMP 4.55%

IMMX -7.76%

IMNM -1.65%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX -0.84%

IMTX -1.58%

IMTXW 6.00%

IMUX 1.56%

IMV 0.00%

IMVT -3.62%

INAB 0.59%

INBX 0.46%

INCY -0.89%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM -2.20%

INMB 2.65%

INO -1.82%

INSM -0.77%

INTS -2.75%

INVA 0.22%

INZY 0.92%

IOBT -11.02%

IONS 0.06%

IOVA -2.31%

IPA 2.46%

IPHA 5.58%

IPSC -1.95%

IRON -2.35%

ISEE 0.38%

ITOS -1.57%

ITRM 1.67%

IVA 6.96%

IVVD -3.72%

JAGX 1.04%

JANX -4.26%

JAZZ -0.54%

JNCE 0.00%

JSPR -6.20%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.94%

KALV -2.16%

KDNY 0.22%

KMPH -0.34%

KNSA -2.95%

KNTE -0.38%

KOD -6.72%

KPRX 0.96%

KPTI -1.83%

KRBP -10.00%

KRON 1.05%

KROS -1.18%

KRRO -6.34%

KRTX 0.03%

KRYS -0.89%

KTRA 17.17%

KTTA 8.16%

KTTAW 0.92%

KURA -1.81%

KYMR -2.26%

KYTX -3.49%

KZIA 5.16%

KZR -1.49%

LABP 0.57%

LBPH -0.89%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.65%

LENZ -4.07%

LEXX 0.00%

LEXXW -14.63%

LGND -1.30%

LGNDV 0.00%

LGVN -8.51%

LIAN -8.28%

LIFE 2.70%

LIPO -7.10%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 0.70%

LPCN -5.03%

LPTX -1.65%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 0.25%

LUMO -1.32%

LVTX 0.00%

LXEO -4.83%

LXRX -2.06%

LYEL -35.47%

LYRA 2.71%

MACK 0.10%

MBIO -9.02%

MBRX -1.72%

MCRB 1.36%

MDGL -2.64%

MDNA -13.16%

MDWD 0.10%

MDXG -2.58%

MEIP -0.13%

MESO -1.78%

MGNX -3.03%

MGTA -7.74%

MGTX -2.61%

MGX -2.68%

MIRM -1.42%

MIRO 0.59%

MIST 1.54%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX -0.63%

MLYS -5.75%

MNKD -1.14%

MNMD 0.28%

MNOV 2.11%

MNPR -5.01%

MOLN 0.28%

MOR 1.06%

MORF -3.70%

MREO -4.14%

MRKR 2.68%

MRNA -4.83%

MRNS -4.04%

MRSN -2.62%

MRTX -0.17%

MRUS 0.26%

MRVI -1.97%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -1.08%

MYMD 8.38%

NAMS 1.37%

NAMSW 0.43%

NAUT 1.14%

NBRV 0.71%

NBSE -1.56%

NBTX 8.61%

NCNA 1.09%

NERV -1.87%

NEXI 2.60%

NGM -1.28%

NGNE -1.40%

NKGN 5.88%

NKGNW 8.00%

NKTR -3.27%

NKTX -4.57%

NLSP -2.77%

NLSPW 26.67%

NMRA -0.74%

NMTR -42.97%

NOVN -24.84%

NRBO 12.16%

NRIX -0.63%

NRSN -3.63%

NRSNW 0.00%

NRXP -5.39%

NRXPW 18.33%

NRXS 4.82%

NTBL 5.06%

NTEC -12.45%

NTHI 0.00%

NTLA -6.17%

NTRBW -31.07%

NUVL -2.15%

NVAX -1.57%

NVCT 3.58%

NVIV -34.28%

NXTC -2.95%

NYMX -0.05%

OABI 0.40%

OABIW -10.06%

OBIO -3.21%

OBSV 0.00%

OCEA 0.00%

OCGN 4.26%

OCS -1.02%

OCUL -1.83%

OCUP 1.97%

ODT -4.27%

OKYO 1.51%

OLMA -5.63%

OMER -0.90%

OMGA 6.25%

ONCO 7.71%

ONCR -3.08%

ONCS 31.87%

ONCT -1.87%

ONCY 0.99%

ONTX -0.47%

ONVO 0.99%

OPNT 0.00%

OPT 1.03%

ORGS -4.53%

ORIC -3.42%

ORMP 15.18%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.81%

OVID -1.43%

OYST 0.00%

PALI -0.87%

PASG -1.31%

PBLA -7.50%

PBM -8.30%

PBYI 1.69%

PCSA 0.00%

PCVX -0.23%

PDSB -0.80%

PEPG 1.70%

PGEN -3.59%

PHAR 1.51%

PHAS 0.00%

PHAT -1.26%

PHIO -3.62%

PHIOW 36.47%

PHVS -7.22%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -0.73%

PLUR 6.01%

PMN 0.72%

PMVP -1.19%

PNT 0.16%

PPBT 0.28%

PRAX 0.63%

PRDS 0.93%

PRLD 0.00%

PROG -3.47%

PROK 0.89%

PRQR -0.01%

PRTA -2.34%

PRTC 0.49%

PRTG -0.50%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -5.11%

PSTX -1.17%

PTCT -0.16%

PTE -0.82%

PTGX -1.64%

PTIXW -49.04%

PULM 2.62%

PXMD 0.00%

PYPD 0.07%

PYXS 3.59%

QLGN -3.72%

QNCX 5.70%

QNRX 0.37%

QSI -11.93%

QSIAW -3.13%

QTTB -4.54%

QURE -0.22%

RAIN -1.63%

RANI 6.42%

RAPT -3.22%

RARE 1.22%

RCKT -8.08%

REGN -0.74%

RENB -3.42%

REPL -3.00%

RETA 0.02%

REUN -0.89%

REVB -1.42%

REVBU 3.46%

REVBW 4.38%

RGLS -4.91%

RGNX -5.19%

RIGL -3.29%

RLAY -4.60%

RLMD 0.33%

RLYB -0.34%

RNA -0.36%

RNAC -5.65%

RNAZ -0.96%

RNXT 1.88%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.31%

RPRX 0.30%

RPTX -2.05%

RUBY 2.70%

RVLP -32.05%

RVMD -1.15%

RVMDW -30.00%

RVNC 1.70%

RVPH -1.02%

RVPHW 1.62%

RXDX 0.09%

RXRX -3.41%

RYTM -6.25%

RYZB 0.02%

RZLT 1.29%

SABS -1.37%

SABSW -11.81%

SAGE 1.56%

SANA -4.24%

SAVA -0.26%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 5.50%

SCPH -0.25%

SCPS 0.00%

SEEL -4.09%

SEER -0.44%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.01%

SGMT -1.69%

SGTX -2.56%

SIOX 22.63%

SLDB -4.73%

SLGL 4.00%

SLN -4.21%

SLNO -2.82%

SLRX 5.91%

SLS -2.99%

SMMT -2.75%

SNDX 0.72%

SNGX -3.02%

SNPX -0.81%

SONN -1.08%

SPPI -0.49%

SPRB 0.30%

SPRC -4.17%

SPRO 0.04%

SRNE -34.00%

SRPT -1.16%

SRRA 0.00%

SRRK -2.35%

SRZN -2.45%

STAB 0.00%

STOK -4.88%

STRO -2.68%

STSA 0.00%

STTK -4.78%

SURF -0.93%

SVRA -2.89%

SWTX 0.33%

SYBX -1.94%

SYRS -1.72%

TALS -0.73%

TARA -8.06%

TARS 0.08%

TBPH 0.48%

TCBP 2.74%

TCDA 0.00%

TCON -2.43%

TCRR 0.00%

TCRT 1.59%

TCRX 2.67%

TECH -0.07%

TENX -1.27%

TERN -6.62%

TFFP -3.05%

TGTX -2.71%

THRX 0.12%

TIL -0.20%

TLC 0.00%

TLSA -4.13%

TNGX -2.27%

TNXP -5.59%

TNYA -8.93%

TPST 2.42%

TRDA -3.86%

TRVI 1.15%

TRVN 5.02%

TSHA -23.94%

TSVT -3.06%

TTNP -9.27%

TVTX 0.63%

TYRA -8.19%

UBX -2.12%

UNCY -3.40%

URGN -1.94%

UTHR -0.28%

VACC 11.36%

VALN -2.89%

VAXX 87.50%

VBIV 0.78%

VBLT -8.77%

VCEL 0.29%

VCNX 10.35%

VCYT -1.23%

VERA -2.80%

VERU 0.73%

VERV -2.58%

VIGL 5.11%

VINC 1.62%

VIR 0.65%

VIRI -1.61%

VIRX 2.38%

VKTX -1.05%

VLON -13.04%

VNDA -2.36%

VOR -2.41%

VRCA 0.28%

VRDN -4.07%

VRNA -1.20%

VRPX 0.38%

VRTX 0.10%

VSTM -3.40%

VTGN -0.46%

VTVT -2.97%

VTYX -0.21%

VXRT -2.26%

VYGR -1.66%

VYNE -3.47%

VYNT 7.78%

WINT -3.24%

WVE -4.40%

XBIO 0.93%

XBIT 1.46%

XCUR 3.61%

XENE -3.11%

XERS 2.38%

XFOR 3.11%

XLO 4.43%

XLRN 0.00%

XNCR 0.05%

XOMA -3.14%

XOMAO 0.36%

XOMAP -0.82%

XRTX -8.92%

YMAB -1.80%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.24%

ZNTL -2.98%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-11-28	Desai Arjun Jj	Buy	33 040	Stock Options (Right to buy)
2023-11-28	Jacobovitz Shalom	Buy	42 736	Stock Options (Right to buy)
2023-11-28	Matlin David J	Buy	56 024	Stock Options (Right to buy)
2023-11-28	Kiernan Matthew	Buy	28 730	Stock Options (Right to buy)
2023-11-28	Mosca Alison	Buy	43 814	Stock Options (Right to buy)

INSIDER POWER
99.46
Last 99 transactions
Buy: 47 544 964 \| Sell: 666 194

सहसंबंध (AI algo v.1.1b): Overvalued: -5.52% $0.0299 paired level. (एल्गो वास्तविक समय में सबसे अधिक सहसंबंधित स्टॉक्स के परिवर्तनों का ट्रैक करता है और तत्काल अद्यतन देता है)

Clene Inc. सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
HDL	0.922
RAY	0.918

10 सबसे अधिक नकारात्मक सहसंबंध
BOTT	-0.804

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Clene Inc. वित्तीय

Annual	2023
राजस्व:	$654 000
सकल लाभ:	$-1.17M (-179.20 %)
EPS:	$-0.470

FY	2023
राजस्व:	$654 000
सकल लाभ:	$-1.17M (-179.20 %)
EPS:	$-0.470

FY	2022
राजस्व:	$473 000
सकल लाभ:	$447 000 (94.50 %)
EPS:	$-0.230

FY	2021
राजस्व:	$723 000
सकल लाभ:	$434 000 (60.03 %)
EPS:	$0

Financial Reports:

No articles found.

Clene Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain\'s energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson\'s Diseases. The company\'s products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.